Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22Neoplasms 20Lung Neoplasms 10Colorectal Neoplasms 8Uterine Cervical Neoplasms 6Papillomavirus Infections 5Head and Neck Neoplasms 5Fatigue 5Multiple Myeloma 4Lymphoma 4Hematologic Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Prostatic Neoplasms 3Melanoma 3Hematopoietic and Lymphoid System Neoplasm 3Gastrointestinal Neoplasms 3Sleep Wake Disorders 2Skin Cancer Prevention 2Obesity 2Neoplasm Metastasis 2Motor Activity 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hematopoietic and Lymphatic System Neoplasm 2Diabetes Mellitus 2Depression 2Caregiver 2Cancer Survivor 2

Interventions

relacorilant 4Resistance Training 3Pioglitazone 3Dipeptidyl-Peptidase IV Inhibitors 3Sulfonylurea Compounds 2Rosiglitazone 2Nutritional Status 2Metformin 2voglibose 1saxagliptin 1repaglinide 1pembrolizumab 1miglitol 1metahexamide 1meglitinide 1glymidine 1glisoxepide 1gliquidone 1glimepiride 1glibornuride 1empagliflozin 1Vildagliptin 1Troglitazone 1Tolbutamide 1Tolazamide 1Thiazolidinediones 1Surveys and Questionnaires 1Sodium-Glucose Transporter 2 Inhibitors 1Sitagliptin Phosphate 1Resistant Starch 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Diabetes Mellitus, Type 2 × Educational Status × Clear all
NCT04938869 2023-02-24

Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients With Poorly Controlled Type 2 Diabetes and Active Cancer

Ohio State University Comprehensive Cancer Center

Phase NA Completed
3 enrolled

Diabetes Mellitus, Type 2

Data powered by HemOnc (CC BY 4.0) Colophon âš¡